Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tabata

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Prostate Cancer and Prostatic Diseases|December 24, 2008
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancerK Tabata, M Watanabe, K Naruishi, et al.
Cancer Gene Therapy|February 18, 2006
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancerK Naruishi, T L Timme, N Kusaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase)M Matsuki, F Yamashita, A Ishida-Yamamoto, et al.
Gene Therapy|October 7, 2006
Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancerT Fujita, T L Timme, K Tabata, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Prostate Cancer and Prostatic Diseases|December 24, 2008
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancerK Tabata, M Watanabe, K Naruishi, et al.
Cancer Gene Therapy|February 18, 2006
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancerK Naruishi, T L Timme, N Kusaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase)M Matsuki, F Yamashita, A Ishida-Yamamoto, et al.
Gene Therapy|October 7, 2006
Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancerT Fujita, T L Timme, K Tabata, et al.
Pageof 14